Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC Science Clips
COVID-10 GPH

Last data update: Dec 02, 2024. (Total: 48272 publications since 2009)
(Author names in bold with hyperlink are CDC authors)
Filtered By:
Order By:
Records 1-1 (of 1 Records)
Query Trace: Sheppard MJ[original query]
Syndromic surveillance for e-cigarette, or vaping, product use-associated lung injury
Hartnett KP , Kite-Powell A , Patel MT , Haag BL , Sheppard MJ , Dias TP , King BA , Melstrom PC , Ritchey MD , Stein Z , Idaikkadar N , Vivolo-Kantor AM , Rose DA , Briss PA , Layden JE , Rodgers L , Adjemian J .
N Engl J Med 2019 382 (8) 766-772

On August 1, 2019, the first cases of electronic cigarette (e-cigarette), or vaping, product use–associated lung injury (EVALI) were reported to the Centers for Disease Control and Prevention (CDC).1 The cluster was an initial signal of an outbreak that by December 17, 2019, had resulted in 2506 cases involving hospitalized patients being reported to the CDC. Most patients with EVALI have been men and adolescent boys (67%), have been younger than 35 years of age (78%), and have reported using e-cigarette products containing tetrahydrocannabinol (THC) (80%).2
TOP